GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of GMDA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for Gamida Cell Ltd. stock after losing 0%
(Updated on Apr 18, 2024)

Hold candidate since Apr 09, 2024 PDF

No changes to the price of Gamida Cell Ltd. stock on the last trading day (Thursday, 18th Apr 2024). During the last trading day the stock fluctuated 0% from a day low at $0.0327 to a day high of $0.0327. The price has been going up and down for this period, and there has been a -18.25% loss for the last 2 weeks.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

GMDA Signals & Forecast

There are mixed signals in the stock today. The Gamida Cell Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0327 and $0.209. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Friday, April 05, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Gamida Cell Ltd. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $0.0307 (-6.18%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 9 days ago.)

Trading Expectations (GMDA) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Gamida Cell Ltd. to open at $0.0327, and during the day (based on 14 day Average True Range), to move between $0.0114 and $0.0540, which gives a possible trading interval of +/-$0.0213 (+/-65.08%) up or down from last closing price. If Gamida Cell Ltd. takes out the full calculated possible swing range there will be an estimated 130.16% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.0361, some $0.0034 (10.40%) from the current price of $0.0327, our system finds the risk reward not very attractive.

Is Gamida Cell Ltd. stock A Buy?

Gamida Cell Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Gamida Cell Ltd. of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$0.0327 ( 0%) $0.0327

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for GMDA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0327 .
R2 0.0327 .
R1 0.0327 .
Current price: 0.0327
Support S1 0.0327 .
S2 0.0327 .
S3 0.0327 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0400 22.32 %
R2 0.0373 14.07 %
R1 0.0361 10.40 %
Current price 0.0327
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Gamida Cell Ltd. Stock and on which exchange is it traded?
The symbol for Gamida Cell Ltd. is GMDA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Gamida Cell Ltd. Stock?
Gamida Cell Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Gamida Cell Ltd. Stock?
Gamida Cell Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Gamida Cell Ltd. Stock.

What's the current price of Gamida Cell Ltd. Stock?
As of the end of day on the 2024-04-18, the price of an Gamida Cell Ltd. (GMDA) share was $0.0327.

What is the 52-week high and low for Gamida Cell Ltd. Stock?
The 52-week high for Gamida Cell Ltd. Stock is $2.51 and the 52-week low is $0.0303.

What is the market capitalization of Gamida Cell Ltd. Stock?
As of the 2024-04-18, the market capitalization of Gamida Cell Ltd. is 4.337M.

When is the next earnings date for Gamida Cell Ltd.?
The upcoming earnings date for Gamida Cell Ltd. is May 20, 2024.
Click to get the best stock tips daily for free!

About Gamida Cell Ltd.

Gamida Cell Ltd. Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based can... GMDA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT